DS Brar

Mr. D S Brar has been a director of Wockhardt "since April 2012. He is a B.E. (Electrical) from Thapar Institute of Engineering & Technology, Patiala, and holds a master’s degree in Management (Gold Medallist) from Faculty of Management Studies, University of Delhi. Mr. Brar has been associated with the pharmaceutical industry for over three decades and his major stint was at Ranbaxy Laboratories, where he rose to become the CEO & Managing Director. Mr. Brar was a Member of the Prime Minister’s Task Force on pharmaceuticals and knowledge-based industries. Mr. Brar also served as a director of Reserve Bank of India, member on the Board of National Institute of Pharmaceutical Education & Research, and member of the Board of Governors of Indian Institute of Management, Lucknow. He is currently member of the Consultative Group on Exports of Pharmaceutical Products under the chairmanship of the Hon’ble Minister of Commerce, Industry & Textiles, Government of India." [1]

In 2011 "Kohlberg Kravis Roberts & Co. (KKR), the global private equity giant with $61.9 billion under management, has appointed former Ranbaxy Laboratories CEO DS Brar as a senior advisor." [2]

"Brar, who worked with Ranbaxy from 1977 to 2004, played a pivotal role in making it India's largest drug maker with an extensive international footprint. He was closely associated with Parvinder Singh, the late chairman and managing director of the company that Sun Pharmaceuticals is taking over from Japan's Daiichi Sankyo in a record $4-billion deal." [3]

• Former chairman of GVK Bio